Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.
Roy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA 50011, USA.
Int J Mol Sci. 2024 Aug 30;25(17):9424. doi: 10.3390/ijms25179424.
Zika virus (ZIKV; family, ), which causes congenital Zika syndrome, Guillain-Barré Syndrome, and other severe diseases, is transmitted mainly by mosquitoes; however, the virus can be transmitted through other routes. Among the three structural and seven nonstructural proteins, the surface envelope (E) protein of ZIKV plays a critical role in viral entry and pathogenesis, making it a key target for the development of effective entry inhibitors. This review article describes the life cycle, genome, and encoded proteins of ZIKV, illustrates the structure and function of the ZIKV E protein, summarizes E protein-targeting entry inhibitors (with a focus on those based on natural products and small molecules), and highlights challenges that may potentially hinder the development of effective inhibitors of ZIKV infection. Overall, the article will provide useful guidance for further development of safe and potent ZIKV entry inhibitors targeting the viral E protein.
Zika 病毒(ZIKV;家族,)可导致先天性 Zika 综合征、格林-巴利综合征和其他严重疾病,主要通过蚊子传播;然而,该病毒也可以通过其他途径传播。在三种结构蛋白和七种非结构蛋白中,ZIKV 的表面包膜(E)蛋白在病毒进入和发病机制中起着关键作用,使其成为开发有效进入抑制剂的关键靶点。本文综述了 ZIKV 的生命周期、基因组和编码蛋白,阐述了 ZIKV E 蛋白的结构和功能,总结了针对 E 蛋白的进入抑制剂(重点介绍基于天然产物和小分子的抑制剂),并强调了可能阻碍有效 ZIKV 感染抑制剂开发的挑战。总的来说,本文将为进一步开发针对病毒 E 蛋白的安全有效的 ZIKV 进入抑制剂提供有益的指导。